Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zileuton in Bronchial Dysplasia
NCT00056004Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Jun 2003
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bronchial dysplasia comparing Zileuton with Placebo (2 arms). Primary endpoint: Bronchial dysplasia number and grade at 6 months. Started Jun 2003; status: completed.
02
Drugs
zileuton extended release
03
Conditions
bronchial dysplasia
Beyond the preview
Go deeper on NCT00056004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00056004.